![Paul Woodward](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 475 036 $ am 31.05.2026
Paul Woodward is President, Chief Executive Officer & Director at Advanced Proteome Therapeutics Corp.
since 2018.
Mr. Woodward is President, Chief Executive Officer & Director at Aether Catalyst Solutions, Inc. since 2014.
Mr. Woodward is Chief Financial Officer & Director at Railtown AI Technologies, Inc. since 2020.
Mr. Woodward is President & Director at Conation Capital Corp.
since 2012.
Mr. Woodward was President, Chief Executive Officer & Director at Linceis Capital Corp.
from 2018 to 2024.
Mr. Woodward completed undergraduate studies at Simon Fraser University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.05.2026 | 1’472’155 ( 0.75% ) | 419 564 $ | 31.05.2026 | |
| 31.12.2025 | 4’267’100 ( 5.66% ) | 55 472 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Vorstandsvorsitzender | 01.12.2018 |
| AETHER CATALYST SOLUTIONS, INC. | Vorstandsvorsitzender | 01.07.2014 |
| RAILTOWN AI TECHNOLOGIES INC. | Finanzdirektor/CFO | 01.08.2016 |
Conation Capital Corp.
 Conation Capital Corp. Financial ConglomeratesFinance Operates as an investment holding company | Präsident | 01.03.2012 |
| Unternehmen | Position | Ende |
|---|---|---|
Linceis Capital Corp.
 Linceis Capital Corp. Financial ConglomeratesFinance Provides investment services | Vorstandsvorsitzender | 01.05.2024 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Advanced Proteome Therapeutics Corp.
 Advanced Proteome Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes chemical & protein therapeutics | Health Technology |
Railtown AI Technologies, Inc.
 Railtown AI Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides artificial intelligence technology services to help developers unlock their full potential | Commercial Services |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Conation Capital Corp.
Conation Capital Corp. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Aether Catalyst Solutions, Inc.
 Aether Catalyst Solutions, Inc. Auto Parts: OEMProducer Manufacturing Develops catalyst to replace the costly precious metals currently utilized in automotive catalytic converters | Producer Manufacturing |
Linceis Capital Corp.
Linceis Capital Corp. Financial ConglomeratesFinance Provides investment services | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
